The global disposable syringes market size is expected to reach USD 11.19 billion by 2026, growing at a CAGR of 5.6% during the forecast periods according to a new study published by Polaris Market Research. The Report ‘Disposable Syringes Market By Product Syringes Type (safety and conventional); By Application (Immunization Injections, Therapeutic Injections); By Region: Segment Forecast 2018-2026’ provides a thorough and detailed analysis into the workings with an overview of present trends and future insights.
Plastic is the material used in manufacturing disposable types, having gradually eclipsed useable ones. Furthermore, approvals acquired for growing number of injectable drugs have notched up an unparalleled pace for use and throw types market potential in comparison to conventional type of syringes. Accidental needlestick injuries with used types have given way to use and throw types market that are effectively safe and free from needlestick injuries.
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/disposable-syringes-market/request-for-sample
Use and throw types are more reliable than other types in self-administration of drugs, owing to many safety features accompanying them. This is especially valid for point of care systems which is currently advocating self administration of drugs.
Intravenous and Intramuscular are the two chosen modes of drug delivery. Disposable ones are to be relied upon to give medication through the above two modes; namely intravenous and intramuscular. They are cost conscious and keep infection at bay. They score over conventional types here.
North America is leader in the segment but soon will be offset by expanding Asia pacific in the forecast period. The drivers to disposables market can be attributed to favorable Government initiatives and directives that have pursued market growth. Government initiatives to check spread of fatal diseases such as HIV also boosts market over coming years.
Europe is second largest market in forecast period. Both America and Europe will consolidate share owing to higher number of injectable drugs that are occupying volume lately. Furthermore, concerns of stick injuries and improvements in quality have given impetus to growth.
Complete Summary with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/disposable-syringes-market
Key players play an active part by focusing on product improvement and increasing number of clinical trials, thus consolidating presence in the region. North America is leading consumer of disposal syringes today. Half of the revenue earned is contributed by North America itself but might lose some of its dominance to expanding Asia Pacific. Europe retains second largest position in the market with both America and Europe attributing dominance to large number of injectable drugs available today.
China and India are valued as most important players in the use and throw type today, due to growing healthcare infrastructure and high population densities in the two nations. Furthermore large-scale immunization drives carried out at the behest of Government is noted for driving growth in market today. Active interest shown by US and Europe in both India and China by providing quality syringes pushes it notches further.
Avail discount on this report @ https://www.polarismarketresearch.com/industry-analysis/disposable-syringes-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
The global disposable syringes market size is expected to reach USD 11.19 billion by 2026, growing at a CAGR of 5.6% during the forecast periods according to a new study published by Polaris Market Research.
The Report ‘Disposable Syringes Market By Product Syringes Type (safety and conventional); By Application (Immunization Injections, Therapeutic Injections); By Region: Segment Forecast 2018-2026’ provides a thorough and detailed analysis into the workings with an overview of present trends and future insights.
Accidental needlestick injuries with used types have given way to use and throw types market that are effectively safe and free from needlestick injuries.
North America is leader in the segment but soon will be offset by expanding Asia pacific in the forecast period.
Government initiatives to check spread of fatal diseases such as HIV also boosts market over coming years.
Furthermore, concerns of stick injuries and improvements in quality have given impetus to growth.
Global Injectable Drug Delivery Devices Market Research Report: Information by Devices (Conventional Injection Devices and Self-Injection Devices), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders and Cancer), Usage Pattern (Curative pattern and Immunization), Site of Delivery (Intramuscular, Subcutaneous and Intra Dermal), Distribution Channel (Hospital & Retail Pharmacies and Online Platforms), Facility of Use (Hospitals and Clinics and Home Care Settings) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027Injectable drug delivery devices are used in administrating the medication into the circulatory system.
Furthermore, the increasing occurrence of needle-stick injuries, rising prevalence of chronic diseases, and increasing uses of biologics such as factors are escalating the market on the global platform.Acknowledging the increasing market size of the market, Market Research Future (MRFR) in its recently published study report asserts that the global injectable drug delivery devices market will garner exponential accruals registering 11.8% CAGR during the review period (2017 – 2023).Additional factors positively impacting the market growth include technological advancements, improving outcomes and patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare.On the other hand, factors such as the safety concerns regarding the use of injectable, risk of blood-borne infections, and the introduction of the alternative drug delivery devices are expected to impede the market growth of these devices.Global Injectable Drug Delivery Devices Market – SegmentationsMRFR has segmented its analysis into four Key dynamics for an easy grasp;By Types : Devices (self-injection devices and conventional injection devices) and Formulations (conventional drug delivery, novel drug delivery, and others.
North America is a well-developed region with the highest GDP, worldwide, which helps the region to have the edge over other regions in terms of every aspect including healthcare and technology.
Factors such as the huge patient pool suffering from chronic diseases such as diabetes and cancer, the presence of geriatric population and development in medical technology are supporting the growth of the market.Certainly, the high economic growth is a key force driving the market growth in the region, allowing access to the quality of life for the people.
The US, backed by the high per capita healthcare expenditures, contributes to the growth of the regional market, significantly.
Owing to the augmenting demand for the injectable drug delivery devices, the region is projected to create a larger revenue pocket in the global market by 2023.The European region stands the second-largest position in the global injectable drug delivery devices market.
To order this detailed 600+ page report, please visit this link Key InclusionsAn overview of the current market landscape of companies engaged in developing and / or manufacturing autoinjectors, providing information on the usability (disposable and reusable), type of primary drug container (cartridge, syringe and vial), volume of container, type of dose (fixed and variable), route of administration (intradermal, intramuscular and subcutaneous), actuation mechanism (automatic and manual) and feedback mechanism integrated in the device.
It also provides details on the developers, highlighting their year of establishment, company size (small-sized, mid-sized and large), location of headquarters and location of manufacturing facilitiesInformation on companies that are developing drugs in combination with autoinjectors, featuring details on initial year of approval (for marketed products), phase of development, usability of the device, route of administration (intracavernous, intramuscular and subcutaneous), type of drug molecule (antibody, peptide, protein and small molecule), dose strength, therapeutic area and other approved dosage forms (for marketed products).
In addition, the section provides details on the company, including year of establishment, company size and location of headquartersA competitiveness analysis of various disposable and reusable autoinjectors, taking into consideration supplier power (based on year of establishment and company size) and key product specifications, such as route of administration, primary drug container used, injector actuation mechanism, type of dose and user friendliness of the product.An in-depth analysis of the various patents that have been filed / granted related to autoinjectors, till August 2019, highlighting details on key parameters, such as type of patent, publication year, issuing authority, CPC classification, emerging focus areas and leading industry players (on the basis of number of patents).
It also includes a detailed patent benchmarking and an insightful valuation analysis.A detailed brand positioning analysis of leading industry players (shortlisted on the basis of strength of product portfolio), highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects, such as strength and diversity of product portfolio, route of administration, actuation mechanism, geographical presence / reach and supplier power of each company.A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with autoinjectors in the near future, shortlisted on the basis of an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).A list of key opinion leaders (KOLs) within this domain who were short-listed based on their contributions (such as involvement in clinical trials and being mentioned in patent applications); it features a schematic world map representation, highlighting the geographical locations of eminent scientists / researchers engaged in this domain.Detailed case studies on the most commonly targeted indications, covering history of development and detailed description of the approved autoinjector products, along with their respective mechanisms of action and historical sales records; the study provides a list of all the drugs that are currently being delivered via autoinjectors.A case study on the role of CMOs offering services for drug delivery devices; it features a list of service providers, highlighting the various types of services offered for different types of drug-delivery devices.A SWOT analysis capturing the key parameters and trends that are likely to influence the future of autoinjectors market.Elaborate profiles of autoinjector manufacturers that have more than three devices in their respective product portfolios; each profile features an overview of the company, its financial information (if available), information on its product portfolio, autoinjector device specifications, collaborations, recent developments and an informed future outlook.
Additionally, the report includes brief profiles of emerging players that have been established in the past decade.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:UsabilityDisposableReusableRoute of administrationSubcutaneousIntramuscularType of moleculeAntibodyPeptideProteinSmall moleculeTherapeutic indicationAnaphylaxisDiabetesMigraineMultiple sclerosisRheumatoid arthritisOther indicationsKey geographical regionsNorth AmericaEuropeAsia-PacificRest of the World The report features inputs from eminent industry stakeholders, according to whom autoinjectors address several limitations of conventional parenteral drug delivery process, by preventing accidental needle-stick injuries, dosing errors and are preferred even by patients with trypanophobia.
Gojek - Co-CEO of go-Jek Andre Soelistyo said, the task of leadership in the company did not change much after Nadiem Makarim choose to become minister-President Joko Widodo (Jokowi).
He said, the Website makes significant progress to be able to record a profit.
The second challenge, the product that the Website developed requires more coordination and collaboration with the ecosystem larger.
(Read: Co-CEO of go-Jek Prepare the IPO in the Two Countries, There are Three Terms)
With a variety of challenges and how to overcome it, according to him, the Website made significant progress to profit.
They are also asking permission to be able to operate in the Philippines and Malaysia.
